David Katz Email

Founder & CSO . Sparrow Pharmaceuticals

Current Roles

Employees:
11
Revenue:
$1.1M
About
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
Sparrow Pharmaceuticals Address
920 SW 6th Avenue
Portland, OR
Sparrow Pharmaceuticals Email

Past Companies

Sparrow Pharmaceuticals, Inc.Founder & CSO
Sparrow Pharmaceuticals, Inc.Founder & CEO
Oregon Health & Science UniversityEntrepreneur In Residence

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.